首页 > 用药指导 > 文章详情

Baricitinib(巴瑞替尼)艾乐明的功效、副作用与注意事项

发布时间:2024-04-15 17:05:23 阅读:886 来源:问药网
分享至

分享到微信朋友圈

×

打开微信,点击底部的“发现”,

使用“扫一扫”即可将网页分享至朋友圈。

巴瑞替尼片

巴瑞替尼片 生产厂家:孟加拉方圆制药Square Pharmaceuticals 功能主治:JAK1/2抑制剂,用于多种炎症性疾病和自身免疫性疾病 用法用量:用法用量  1、类风湿性关节炎  OLUMIANT的推荐剂量为每日1次口服2mg,餐前餐后都可。  OLUMIANT可以单独使用,也可以与甲氨蝶呤或其他非生物dmard联合使用。  2、COVID-19(新冠病毒)  成人OLUMIANT的推荐剂量为每日一次口服4mg,餐前餐后都可,持续14天或直到出院,以先发生者为准。  3、斑秃  OLUMIANT的推荐剂量是2mg,每天一次口服,餐前餐后都可。  如果对治疗的反应不充分,增加到每天一次4mg。  对于几乎完全或完全的头皮脱发,睫毛或眉毛有或没有大量脱发的患者,考虑每天一次4mg治疗,伴餐前餐后都可。  一旦患者对4mg的治疗产生了充分的反应,将剂量减少到2mg,每天一次。  对于无法吞下整片药片的患者,可以考虑另一种给药方式:  1、口服分散  2、胃造口管(G管)  3、鼻胃管(NG管)或口胃管(OG管)
查看详情

Baricitinib(巴瑞替尼)艾乐明的功效、副作用与注意事项,Baricitinib(Baricitinib)常见副作用有:1、严重感染,如肺炎、带状疱疹和尿路感染;2、死亡率,50岁以上及有心血管疾病的患者有更高的全因死亡率;3、恶性肿瘤和淋巴增生性疾病;4、重大心血管不良事件;5、血栓形成;6、会出现过敏反应;7、胃肠道穿孔;8、可能会对胎儿造成损害。

Baricitinib (trade name: Olumiant) is a medication used to treat various conditions, including rheumatoid arthritis, COVID-19, and alopecia areata. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors. Baricitinib works by blocking specific enzymes in the body that are involved in the immune response, helping to reduce inflammation and improve symptoms associated with these conditions. However, it is important to be aware of the potential benefits, side effects, and precautions associated with this medication.

1. Effectiveness of Baricitinib:

Baricitinib has shown effectiveness in treating rheumatoid arthritis, a chronic autoimmune disease that causes inflammation in the joints. Clinical studies have demonstrated that baricitinib can reduce the signs and symptoms of rheumatoid arthritis, improve physical function, and slow down the progression of joint damage. It is usually prescribed as a second-line treatment when conventional disease-modifying antirheumatic drugs (DMARDs) have not provided sufficient relief.

2. Use of Baricitinib in COVID-19:

During the COVID-19 pandemic, baricitinib has gained attention as a potential treatment option. It is used in combination with the antiviral drug remdesivir in hospitalized patients with COVID-19 who require supplemental oxygen or mechanical ventilation. Baricitinib is thought to help modulate the immune response and reduce inflammation associated with severe COVID-19. It has been shown to shorten recovery time and decrease the risk of death in some patients.

3. Baricitinib for Alopecia Areata:

Alopecia areata is an autoimmune condition characterized by hair loss on the scalp, face, and other areas of the body. Baricitinib has shown promise in the treatment of moderate to severe cases of alopecia areata. It is believed to work by suppressing the immune system in the affected area, allowing hair regrowth. However, the use of baricitinib for alopecia areata is still being studied, and more research is needed to determine its long-term effectiveness and safety in this condition.

4. Side Effects and Precautions:

Like any medication, baricitinib may cause side effects. The most common side effects include upper respiratory tract infections, headaches, nausea, and an increased risk of developing infections. It may also cause an increase in liver enzyme levels, so regular monitoring of liver function is necessary. Additionally, baricitinib may increase the risk of blood clots, so caution is needed in patients with a history of clotting disorders.

Before starting baricitinib, it is important to inform your healthcare provider about any existing medical conditions, current medications, or allergies. Since baricitinib affects the immune system, it may interfere with the body's ability to fight infections. Therefore, it is important to avoid live vaccines while taking this medication. Pregnant or breastfeeding individuals should discuss the potential risks and benefits with their healthcare provider before starting baricitinib.

In conclusion, baricitinib has proven to be an effective treatment for rheumatoid arthritis and has shown promising results in managing COVID-19 and alopecia areata. However, it is essential to consider the potential side effects and precautions associated with its use. Only a healthcare professional can determine whether baricitinib is appropriate for an individual based on their specific medical condition and needs.